Bayer announced positive topline results from the global phase III QUASAR study evaluating ... Detailed results will be submitted to regulatory authorities worldwide and presented at upcoming medical ...

The Essure device was implanted into women’s fallopian tubes to prevent pregnancy. It left some women with chronic pelvic ...

GE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on ...

The global medical disposables market is witnessing strong momentum, with revenues projected to grow from an estimated USD ...

An investigation conducted by Canada’s National Observer finds that Bayer colluded with Canadian regulators to obstruct a ...

A groundbreaking antipsychotic, a powerful new antibiotic, and a vaccine-like prophylactic for HIV are some of the most ...

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy ...

Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

Most recently, Dr Berger was the Chief Medical Officer and Global Head of Development at Sanofi ... Aside from his over ...

Gilead Sciences named former Sanofi executive Dietmar Berger as chief medical officer, effective Jan. 2, succeeding Merdad Parsey.

Gilead (GILD) announced that Dietmar Berger will join the company on January 2, 2025, as Chief Medical Officer and will become a member of ...

The DEA Museum explores Bayer's early 20th-century marketing of heroin, originally promoted as a "less addictive" morphine ...